CryoTherapeutics
Ans
About CryoTherapeutics
CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intends to extend the benefits of cryoenergy to the problem of diseased coronary arteries.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $33.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2024)
- Website: cryotherapeutics.com
- Phone: 49 331 2300920
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/cryotherapeutics-49634 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.